Biological treatment for bullous pemphigoid

Biological treatment for bullous pemphigoid

BackgroundBullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease. Topical or systemic corticosteroids are often used as the first-line treatment. However, long-term corticosteroid use may lead to significant side effects. Therefore, various adjuvant immunosuppressant ther...

Full description

Bibliographic Details
Main Authors: Meital Oren-Shabtai, Daniel Mimouni, Adi Nosrati, Lihi Atzmony, Baruch Kaplan, Aviv Barzilai, Sharon Baum
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
bullous pemphigoid
autoimmune subepidermal bullous disease
rituximab
dupilumab
omalizumab
corticosteroids
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1157250/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1157250/full

Similar Items